X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse FDC LTD. with ACTAVIS INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FDC LTD.   ACTAVIS
EQUITY SHARE DATA
    FDC LTD.
Mar-14
ACTAVIS
Dec-14
FDC LTD./
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs14417,418-   
Low Rs7910,625-   
Sales per share (Unadj.) Rs47.63,136.6-  
Earnings per share (Unadj.) Rs7.6-391.4-  
Cash flow per share (Unadj.) Rs9.0287.8-  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.56,803.1-  
Shares outstanding (eoy) m177.83265.90-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.34.5 52.3%   
Avg P/E ratio x14.6-35.8 -40.8%  
P/CF ratio (eoy) x12.348.7 25.3%  
Price / Book Value ratio x2.32.1 113.6%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,7843,728,306 0.5%   
No. of employees `000NA21.6 0.0%   
Total wages/salary Rs m1,2210-   
Avg. sales/employee Rs ThNM38,611.5-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-4,818.3-  
INCOME DATA
Net Sales Rs m8,459834,009 1.0%  
Other income Rs m394-2,082 -18.9%   
Total revenues Rs m8,852831,927 1.1%   
Gross profit Rs m2,070107,140 1.9%  
Depreciation Rs m249180,593 0.1%   
Interest Rs m3126,306 0.1%   
Profit before tax Rs m2,184-101,841 -2.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m0-7,470 0.0%   
Tax Rs m606-5,236 -11.6%   
Profit after tax Rs m1,353-104,076 -1.3%  
Gross profit margin %24.512.8 190.5%  
Effective tax rate %27.75.1 539.4%   
Net profit margin %16.0-12.5 -128.2%  
BALANCE SHEET DATA
Current assets Rs m4,355439,416 1.0%   
Current liabilities Rs m1,792320,463 0.6%   
Net working cap to sales %30.314.3 212.5%  
Current ratio x2.41.4 177.3%  
Inventory Days Days4458 76.6%  
Debtors Days Days2566 37.2%  
Net fixed assets Rs m3,025101,841 3.0%   
Share capital Rs m1790-   
"Free" reserves Rs m8,2430-   
Net worth Rs m8,4531,808,934 0.5%   
Long term debt Rs m11947,917 0.0%   
Total assets Rs m10,5573,315,181 0.3%  
Interest coverage x71.4-2.9 -2,487.2%   
Debt to equity ratio x00.5 0.2%  
Sales to assets ratio x0.80.3 318.5%   
Return on assets %13.1-2.3 -558.9%  
Return on equity %16.0-5.8 -278.2%  
Return on capital %23.5-3.0 -780.8%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Net fx Rs m7910-   
CASH FLOW
From Operations Rs m1,485143,216 1.0%  
From Investments Rs m-620-342,913 0.2%  
From Financial Activity Rs m-753192,667 -0.4%  
Net Cashflow Rs m113-7,030 -1.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 63.85 Rs / USD

Compare FDC LTD. With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare FDC LTD. With: DR. REDDYS LAB  PIRAMAL ENTERPRISES  GLENMARK PHARMA  PANACEA BIOTECH  TORRENT PHARMA  



Today's Market

Sensex Ends Above 35,000 Mark; Bank & IT Stocks Outperform(Closing)

After opening the day flat, share markets in India witnessed positive trading activity throughout the day and ended the day on a strong note.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jan 17, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS